Welcome to the Westgerman Prostate Center Cologne

From now on, the West German Prostate Center will inform you regularly in its own newsletter about current developments in the diagnosis and therapy of prostate cancer and benign prostate enlargement, report on new research results and keep you up to date on its own projects and treatment methods.

Priv.-Doz. Dr. Dr. Holger Gerullis and Kai P. Schuster support the West German Prostate Center as additional specialists for urology with immediate effect. This enables the WPZ and the Urology Department of the KLINIK am RING to better meet the increasing number of their patients.

Holmium laser enucleation of the prostate, or HoLEP for short, is one of the most modern procedures for treating benign prostate enlargement. The advantage of this method compared to conventional transurethral resection of the prostate is significantly less blood loss and the possibility to operate on very large glands.

No other cancer faces such a wide range of opinions. Large international studies have shown that radiotherapy has at least the same cure rates for prostate cancer in the early stages and superior cure rates in advanced diesase compared to surgery.

The international Prostate Cancer Results Study Group (PCRSG) has developed a unique decision support tool to compare the cure rates of all modern therapies, depending on the risk profile of the tumor. This is based on a scientific analysis of all relevant studies on localized prostate cancer in more than 52,000 patients.

Complaints caused by benign prostate enlargement (benign prostatic hyperplasia) can severely impair the quality of life of those affected and can lead to complications and late complications. A checklist should help you to recognise the first signs and consult a doctor if necessary.

A recently published study has once again confirmed the excellent efficacy of brachytherapy: Ten years after treatment, the biochemical freedom from recurrence was significantly better in patients who received a seed implant than in patients whose prostate had been surgically removed.

International Meta Study proofs: Brachytherapy at least equivalent or superior to Radical Surgery.

The IQWiG Institute rejects prostate cancer screening using the PSA test. The Institute also receives strong criticism from the German Society of Urology (DGU). "With good reason," say Dr Stephan Neubauer and Dr Pedram Derakhshani of the West German Prostate Center in Cologne.

Study by the British Columbia Cancer Agency confirms: high efficacy combined with very low side effects makes brachytherapy treatment of choice for localized prostate cancer.

In benign prostate enlargement, treatment with modern laser techniques not only leads to fewer complications than transurethral resection (TURP) but also has a significantly lower risk of bleeding.

ProtecT study shows: Patients after prostate surgery suffer most from the consequences of treatment.

COPCa study: what treatment do patients choose in low-risk prostate cancer?

HIFU in prostate carcinoma continues experimental procedure.

Being one of the strongest centres in Europe, the WPC has specialised in modern and minimal invasive prostate treatments.

Up to now, experts in the USA had expressly spoken out against a widespread use of the PSA test for the early detection of prostate cancer.